{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:05:36Z","timestamp":1784333136803,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14334-2","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T05:47:40Z","timestamp":1748497660000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Epidemiology, patient management, and survival outcomes in resected patients with non-metastatic non-small cell lung cancer: a nationwide real-world study"],"prefix":"10.1186","volume":"25","author":[{"given":"St\u00e9phane","family":"Renaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Casabianca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Diez-Andreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Chartier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Fran\u00e7oise","family":"Gaudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Bugnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e8ve","family":"B\u00e9nard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois-Emery","family":"Cott\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Chouaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"14334_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jtho.2020.09.012","volume":"16","author":"J-L Pujol","year":"2021","unstructured":"Pujol J-L, Thomas P-A, Giraud P, Denis MG, Tretarre B, Roch B, et al. Lung Cancer in France. J Thorac Oncol. 2021;16:21\u20139.","journal-title":"J Thorac Oncol"},{"key":"14334_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"14334_CR3","unstructured":"Overview of cancers in France, Institut national du Cancer (INCa). 2023 Edition. [Internet]. [Consulted on November 14th, 2023]. Available at: https:\/\/www.e-cancer.fr\/Expertises-et-publications\/Les-donnees-sur-les-cancers\/Incidence-et-mortalite-des-cancers\/Incidence-nationale-des-cancers-en-2023"},{"key":"14334_CR4","doi-asserted-by":"publisher","first-page":"100492","DOI":"10.1016\/j.lanepe.2022.100492","volume":"22","author":"D Debieuvre","year":"2022","unstructured":"Debieuvre D, Molinier O, Falchero L, Locher C, Templement-Grangerat D, Meyer N, et al. Lung cancer trends and tumor characteristic changes over 20 years (2000\u20132020): results of three French consecutive nationwide prospective cohorts\u2019 studies. Lancet Reg Health Eur. 2022;22:100492.","journal-title":"Lancet Reg Health Eur"},{"key":"14334_CR5","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/annonc\/mdx222","volume":"28","author":"PE Postmus","year":"2017","unstructured":"Postmus PE, Kerr KM, Oudkerk M, Senan S, Waller DA, Vansteenkiste J, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol. 2017;28:iv1\u201321.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"14334_CR6","unstructured":"Non-small cell lung cancer. 16th edition. Auvergne Rh\u00f4ne-Alpes referentials in thoracic oncology. [Internet]. [consulted on April 18th, 2023]. Available at: https:\/\/ressources-aura.fr\/wp-content\/uploads\/2020\/04\/CBNPC_2020_VDEF.pdf"},{"key":"14334_CR7","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.3390\/cancers13153711","volume":"13","author":"F Montagne","year":"2021","unstructured":"Montagne F, Guisier F, Venissac N, Baste J-M. The role of surgery in lung Cancer treatment: present indications and future Perspectives\u2014State of the Art. Cancers. 2021;13:3711.","journal-title":"Cancers"},{"key":"14334_CR8","unstructured":"Minist\u00e8re de la Sant\u00e9. Arr\u00eat\u00e9 du 23 d\u00e9cembre 2016 relatif au recueil et au traitement des donn\u00e9es d\u2019activit\u00e9 m\u00e9dicale et des donn\u00e9es de facturation correspondantes, produites par les \u00e9tablissements de sant\u00e9 publics ou priv\u00e9s ayant une activit\u00e9 en m\u00e9decine, chirurgie, obst\u00e9trique et odontologie, et \u00e0 la transmission d\u2019informations issues de ce traitement dans les conditions d\u00e9finies \u00e0 l\u2019article L. 6113-8 du code de la sant\u00e9 publique - L\u00e9gifrance [Internet]. [cited 2025 Mar 24]. Available from: https:\/\/www.legifrance.gouv.fr\/loda\/id\/JORFTEXT000033793735"},{"key":"14334_CR9","unstructured":"Agence Technique de l\u2019Information sur l\u2019Hospitalisation. Contenu des bases PMSI MCO 2022 [Internet]. [cited 2025 Mar 24]. Available from: https:\/\/www.atih.sante.fr\/contenu-des-bases-pmsi-mco-2022"},{"key":"14334_CR10","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/pds.4233","volume":"26","author":"J Bezin","year":"2017","unstructured":"Bezin J, Duong M, Lassalle R, Droz C, Pariente A, Blin P, et al. The National healthcare system claims databases in France, SNIIRAM and EGB: powerful tools for pharmacoepidemiology. Pharmacoepidemiol Drug Saf. 2017;26:954\u201362.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"14334_CR11","unstructured":"INSEE. Annual consumer price index - Base 2015 - All households - Metropolitan France - Health services. 2021. [Internet]. [Consulted on November 14th, 2023]. Available at: https:\/\/www.insee.fr\/fr\/statistiques\/serie\/001765611#Tableau"},{"key":"14334_CR12","unstructured":"Cancers in France. Epidemiology of cancers. French National Cnacer Institute (INCa). [Internet]. [Consulted on April 24th, 2023]. Available at: https:\/\/www.e-cancer.fr\/ressources\/cancers_en_france\/#page=31"},{"key":"14334_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.rmr.2018.01.014","volume":"36","author":"A Bernard","year":"2019","unstructured":"Bernard A, Pag\u00e8s P-B, Mariet A-S, Pforr A, Cottenet J, Quantin C. Evaluation of surgical practice in the treatment of lung cancer in France from the PMSI National database. Rev Mal Respir. 2019;36:31\u20138.","journal-title":"Rev Mal Respir"},{"key":"14334_CR14","doi-asserted-by":"publisher","first-page":"e0182798","DOI":"10.1371\/journal.pone.0182798","volume":"12","author":"C Choua\u00efd","year":"2017","unstructured":"Choua\u00efd C, Debieuvre D, Durand-Zaleski I, Fernandes J, Scherpereel A, Westeel V, et al. Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study). PLoS ONE. 2017;12:e0182798.","journal-title":"PLoS ONE"},{"key":"14334_CR15","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.athoracsur.2014.05.070","volume":"98","author":"F Lou","year":"2014","unstructured":"Lou F, Sima CS, Rusch VW, Jones DR, Huang J. Differences in patterns of recurrence in Early-Stage versus locally advanced Non-Small cell lung Cancer. Ann Thorac Surg. 2014;98:1755\u201361.","journal-title":"Ann Thorac Surg"},{"key":"14334_CR16","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.3390\/cancers13184574","volume":"13","author":"M Alifano","year":"2021","unstructured":"Alifano M, Daffr\u00e9 E, Iannelli A, Brouchet L, Falcoz PE, Le Pimpec Barthes F, et al. The reality of lung cancer.paradox: the impact of body mass index on Long-Term survival of resected lung cancer. A French nationwide analysis from the epithor database. Cancers. 2021;13:4574.","journal-title":"Cancers"},{"key":"14334_CR17","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1183\/13993003.00354-2015","volume":"46","author":"M-C Morgant","year":"2015","unstructured":"Morgant M-C, Pag\u00e8s P-B, Orsini B, Falcoz P-E, Thomas P-A, Barthes FLP, et al. Time trends in surgery for lung cancer in France from 2005 to 2012: a nationwide study. Eur Respir J. 2015;46:1131\u20139.","journal-title":"Eur Respir J"},{"key":"14334_CR18","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3390\/cancers14040874","volume":"14","author":"O Schussler","year":"2022","unstructured":"Schussler O, Bobbio A, Dermine H, Lupo A, Damotte D, Lecarpentier Y, et al. Twenty-Year survival of patients operated on for Non-Small-Cell lung cancer: the impact of tumor stage and Patient-Related parameters. Cancers. 2022;14:874.","journal-title":"Cancers"},{"key":"14334_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/cai2.49","volume":"2","author":"Z Xu","year":"2023","unstructured":"Xu Z, Zou Z, Hao X, Xing P, Li J. Adjuvant and neo-adjuvant immunotherapy in resectable non-small cell lung cancer (NSCLC): current status and perspectives. Cancer Innov. 2023;2:65\u201378.","journal-title":"Cancer Innov"},{"key":"14334_CR20","unstructured":"Algorithm for the selection of cancer-related hospitalizations in MCO - Validation study. French National Cancer Institute (INCa). February 2108. [Internet]. [Consulted on April 24th, 2023]. Available at: https:\/\/www.e-cancer.fr\/Expertises-et-publications\/Catalogue-des-publications\/Algorithme-de-selection-des-hospitalisations-liees-au-cancer-en-MCO-Etude-de-validation"},{"key":"14334_CR21","doi-asserted-by":"publisher","first-page":"3432423","DOI":"10.17061\/phrp3432423","volume":"34","author":"B Brown","year":"2024","unstructured":"Brown B, Young J, Galpin K, Boyer M, Chin V, Brown C, et al. Impact of COVID-19 on lung cancer care in new South Wales, Australia: real-world data from the enrich program. Public Health Res Pract. 2024;34:3432423.","journal-title":"Public Health Res Pract"},{"key":"14334_CR22","doi-asserted-by":"publisher","first-page":"175346662412987","DOI":"10.1177\/17534666241298794","volume":"18","author":"H Pan","year":"2024","unstructured":"Pan H, Chen H, Li W, Tian Y, Ge Z, Kong W, et al. Early outcomes of radical surgery in non-small-cell lung cancer patients with and without COVID-19 history: a multi-center real-world study. Ther Adv Respir Dis. 2024;18:17534666241298794.","journal-title":"Ther Adv Respir Dis"},{"key":"14334_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.21037\/jtd-24-1334","volume":"17","author":"CM Stuart","year":"2025","unstructured":"Stuart CM, Mott NM, Bronsert MR, Dyas AR, Rodriguez Franco S, Gleisner AL, et al. Continued implications of the COVID-19 pandemic environment on non-small cell lung cancer characteristics and treatment in the united States. J Thorac Dis. 2025;17:150\u201360.","journal-title":"J Thorac Dis"},{"key":"14334_CR24","unstructured":"Where do people die. in France? Analysis of death certificates (1993\u20132008). French Agency of Public Health (SPF). December 2012. [Internet]. [Consulted on April 24th, 2023]. Available at: https:\/\/www.santepubliquefrance.fr\/docs\/ou-meurt-on-en-france-analyse-des-certificats-de-deces-1993-2008"},{"key":"14334_CR25","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3892\/ijo.2022.5446","volume":"61","author":"X-E Su","year":"2022","unstructured":"Su X-E, Hong W-P, He H-F, Lin S, Wu S-H, Liu F, et al. Recent advances in postoperative pulmonary rehabilitation of patients with non-small cell lung cancer (Review). Int J Oncol. 2022;61:156.","journal-title":"Int J Oncol"},{"key":"14334_CR26","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1056\/NEJMoa2212083","volume":"388","author":"N Altorki","year":"2023","unstructured":"Altorki N, Wang X, Kozono D, Watt C, Landrenau R, Wigle D, et al. Lobar or sublobar resection for peripheral stage IA Non-Small-Cell lung Cancer. N Engl J Med. 2023;388:489\u201398.","journal-title":"N Engl J Med"},{"key":"14334_CR27","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.3390\/jcm13113354","volume":"13","author":"JA Khan","year":"2024","unstructured":"Khan JA, Albalkhi I, Garatli S, Migliore M. Recent advancements in minimally invasive surgery for early stage Non-Small cell lung cancer: A narrative review. J Clin Med. 2024;13:3354.","journal-title":"J Clin Med"},{"key":"14334_CR28","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.3390\/cancers16173086","volume":"16","author":"JM Pan","year":"2024","unstructured":"Pan JM, Watkins AA, Stock CT, Moffatt-Bruce SD, Servais EL. The surgical renaissance: advancements in Video-Assisted thoracoscopic surgery and Robotic-Assisted thoracic surgery and their impact on patient outcomes. Cancers. 2024;16:3086.","journal-title":"Cancers"},{"key":"14334_CR29","doi-asserted-by":"crossref","unstructured":"Patel SP, Wang R, Zhou SQ, Sheinson D, Johnson A, Lee JS. Validation of an updated algorithm to identify patients with incident Non\u2013Small cell lung Cancer in administrative claims databases. JCO Clin Cancer Inf. 2024;e2300165.","DOI":"10.1200\/CCI.23.00165"},{"key":"14334_CR30","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.cllc.2022.12.005","volume":"24","author":"H West","year":"2023","unstructured":"West H, Hu X, Zhang S, Song Y, Chirovsky D, Gao C, et al. Treatment patterns and outcomes in resected Early-stage Non-small cell lung cancer: an analysis of the SEER-Medicare data. Clin Lung Cancer. 2023;24:260\u20138.","journal-title":"Clin Lung Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14334-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14334-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14334-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T05:47:44Z","timestamp":1748497664000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14334-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14334"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14334-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"1 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been conducted in accordance with International Society for Pharmacoepidemiology guidelines for Good Pharmacoepidemiology Practices and applicable regulatory requirements, including the French Data Protection Agency (Commission Nationale de l\u2019Informatique et des Libert\u00e9s\u2013 CNIL) opinion n\u00b02018\u2009\u2212\u2009257 of June 7, 2018 on regulatory requirements and governance for processing PMSI data under expedited regulatory process (MR-006\u2013 see https:\/\/www.legifrance.gouv.fr\/jorf\/id\/JORFTEXT000037187571). This study was carried out in compliance with the principles set in the Helsinki Declaration. As per MR-006 process, this study only uses secondary data from claims database, qualifying as research not involving human subjects and thus no informed consent or review by an ethics committee is required. Studies carried out using PMSI data must be audited to ensure their compliance with authorized purposes. Also, a collective information note has been added to both st\u00e8ve consultants and BMS websites for this purpose. This information specifies that data subjects have rights of access, rectification and opposition on their data, which may be exercised by contacting the director of the organization managing the compulsory health insurance scheme to which they belong.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable\u2013 as per MR-006 process.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SR reports receiving fees from Medtronic, Intuitive Surgical, Astra-Zeneca, BMS and BD\/BARD for consulting activities. CC reports receiving honoraria from AstraZeneca, Boehringer Ingelheim, Clovis, GlaxoSmithKline, Hoffman-La Roche, Lilly, Pfizer, BMS, MSD, Novartis, Accord Healthcare, Sandoz, Janssen, Takeda, Sanofi, Pierre Fabre and Amgen for congress participation, communications, training and research work. PDI, FB and SB are employees of st\u00e8ve consultants\u2013 a Cytel company\u2013 that has been contracted to conduct this study. PC, MC, AFG and FEC are employees of Bristol Myers Squibb.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"966"}}